Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication

Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical pathology 1982-07, Vol.35 (7), p.740-743
Hauptverfasser:	Aukland, A, Hurlow, R A, George, A J, Stuart, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Arteriosclerosis - complications Clinical Trials as Topic Double-Blind Method Humans Intermittent Claudication - drug therapy Intermittent Claudication - etiology Male Middle Aged Platelet Aggregation - drug effects Random Allocation Thiophenes - therapeutic use Ticlopidine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!